LabConnect, the world’s most agile central laboratory solutions partner, today announced the opening of its new corporate headquarters in Raleigh, North Carolina, strengthening its footprint in the ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Distinguished drug-development and biomarker leader to advance NAMkind™ scientific strategy, translational insights, and next-generation toxicology platforms ...

EASY Residency is a global incubation program under YZi Labs, designed to support early-stage startups in the Web3, AI, and biotechnology fields who are committed to long-term value creation.

He emphasised collaboration between startups and research labs and the need for hands-on experience in AI, quantum computing ...

Breeders did not increase their populations during an investment downturn in 2023, contributing to a supply squeeze.

Europe needs a new system compelling researchers, governments and companies to share risk from the earliest stages of therapy ...

The latest: The nonprofit recently launched LabCentral First, a new program that gives 18 first-time biotech founders six ...

China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...

The cost of the monkeys — a proxy for the volume of clinical trials — is projected to reach Rmb150,000 ($21,000) at the start ...

Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...

In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...